AMARIN CORP PLC\UK

AMRN · Nasdaq · SIC 2834: Pharmaceutical Preparations
308
SEC Filings

Business Summary

- Government Regulation Pharmaceutical Pricing and Reimbursement for further details. In many countries outside the U.S., government-sponsored healthcare systems are the primary payors for drugs. With increasing budgetary constraints and differing views on or challenges in valuing medicines, governments and payors in many countries are applying a variety of measures to exert downward price pressure. These measures can include mandatory price controls, price referencing, therapeutic-reference pri...

Next Earnings

Q2 FY2026 — expected 2026-07-28

Key Facts from Earnings Calls

TypeSubjectDetailQuarter
topic_mentionAMRNdiscussed_in_filing Cybersecurity
topic_mentionAMRNdiscussed_in_filing Cybersecurity
topic_mentionAMRNdiscussed_in_filing Regulation
topic_mentionAMRNdiscussed_in_filing Healthcare & Bio
topic_mentionAMRNdiscussed_in_filing Sovereign & Government
topic_mentionAMRNdiscussed_in_filing Regulation
topic_mentionAMRNdiscussed_in_filing Healthcare & Bio
topic_mentionAMRNdiscussed_in_filing Sovereign & Government

Annual Reports (10-K)

FiledPeriodAccessionSourceFull Text
2026-03-022025-12-310001193125-26-085818EDGAR102K words
2025-03-122024-12-310000950170-25-037620EDGAR—
2024-02-292023-12-310000950170-24-022636EDGAR—
2023-03-012022-12-310000950170-23-005336EDGAR—
2022-03-012021-12-310000950170-22-002401EDGAR—
2021-02-252020-12-310001564590-21-008382EDGAR—
2020-02-252019-12-310001564590-20-006390EDGAR—
2019-02-272018-12-310001564590-19-004655EDGAR—
2018-02-272017-12-310001564590-18-003389EDGAR—
2017-03-012016-12-310001193125-17-065969EDGAR—

Quarterly Reports (10-Q)

FiledPeriodAccessionSourceFull Text
2025-10-292025-09-300001193125-25-254621EDGAR32K words
2025-07-302025-06-300000950170-25-099879EDGAR—
2025-05-072025-03-310000950170-25-064981EDGAR—
2024-10-302024-09-300000950170-24-118990EDGAR—
2024-07-312024-06-300000950170-24-088233EDGAR—
2024-05-012024-03-310000950170-24-050886EDGAR—
2023-11-012023-09-300000950170-23-057120EDGAR—
2023-08-022023-06-300000950170-23-036771EDGAR—
2023-05-032023-03-310000950170-23-016877EDGAR—
2022-10-272022-09-300000950170-22-020246EDGAR—
2022-08-032022-06-300000950170-22-014008EDGAR—
2022-05-042022-03-310000950170-22-007188EDGAR—

Recent Current Reports (8-K)

FiledAccessionSourceFull Text
2026-03-270001193125-26-129334EDGAR1K words
2026-02-250001193125-26-068511EDGAR—
2026-01-080001193125-26-006992EDGAR—
2025-10-290001193125-25-254620EDGAR—
2025-10-220001193125-25-246973EDGAR—
2025-07-300000950170-25-099878EDGAR—
2025-06-240000950170-25-089218EDGAR—
2025-05-150000950170-25-072817EDGAR—
2025-05-070000950170-25-064980EDGAR—
2025-04-290000950170-25-060165EDGAR—

308 total filings indexed. 276 additional filings (S-1, DEF 14A, etc.) View all (JSON) · SEC EDGAR

Sector Peers

SXTP — 60 DEGREES PHARMACEUTICALS, INC. ABT — ABBOTT LABORATORIES ABEO — ABEONA THERAPEUTICS INC. ABVC — ABVC BIOPHARMA, INC. ACAD — ACADIA PHARMACEUTICALS INC ACTU — ACTUATE THERAPEUTICS, INC. ADCT — ADC Therapeutics SA ADIL — ADIAL PHARMACEUTICALS, INC.

Company Identity

CIK0000897448
TickerAMRN
ExchangeNasdaq
SIC2834: Pharmaceutical Preparations
IncorporatedX0

Get More Data

This is the free public profile. For structured JSON with full provenance chain, use the API:

JSON Profile Stock Quote AI Readiness Report
Origin Provenance
page leaf: 2475ba24d1936cfecfb024eb6620d173129ddc8e4d25e4f1567b647be0e1dc08
parent: c280a9bee016ed8de210103cf58771d757e8d619442df09209e7863c749cff54
content hash: 00981874462f7b034057bbb5820aa4a186b1fa46210eeaaa8459893a259c7f6b
signed: 2026-04-13T04:43:38.230Z
sources: 22 verified data leaves
chain: SEC.gov PEM → origin.rootz.global extraction → this page
verify: sha256(content_hash + parent + timestamp) = leaf